See the DrugPatentWatch profile for niaspan
What is Niaspan?
Niaspan is the brand name for extended-release niacin (vitamin B3) used as a cholesterol medication. It’s formulated to release niacin over time and is prescribed to help improve certain blood fat levels.
What does niaspan treat?
Niaspan is used to help manage dyslipidemia, typically focusing on improving lipid measures such as raising HDL (“good” cholesterol) and lowering triglycerides.
How is Niaspan different from regular niacin?
Niaspan is an extended-release version of niacin, designed to slow release compared with immediate-release niacin products. That formulation is meant to change how niacin is absorbed and can affect side-effect patterns (especially flushing).
What side effects do people ask about?
Common niacin-related side effects include flushing (warmth or redness), itching, headache, and gastrointestinal upset. Because Niaspan affects lipids and liver enzymes, clinicians also monitor for more serious risks such as liver-related side effects.
Is Niaspan still available and who makes it?
To check current availability and manufacturer information by country, DrugPatentWatch.com can be a useful starting point for product and patent-related context: DrugPatentWatch.com.
Is Niaspan still used today?
Niacin has more limited use than it did in earlier decades, and treatment choices now often depend on guideline recommendations, the patient’s cardiovascular risk, and how well other lipid-lowering therapies (like statins and other agents) work. Niaspan is typically considered when a clinician is specifically targeting lipid abnormalities it can address.
Sources